We performed a 2 (groups: healthy controls/depression) × 2 (resilience levels: high/low) × 2 (emotional valence: positive/negative) repeated-measures ANOVA for oxy-Hb activation in the LOFC. The gene discussed is GSTM1; the disease is depressive symptom measurement.